On Wednesday, in a statement, CStone Pharmaceuticals stated, a unit of Pfizer Inc has agreed to acquire a 9.9% stake in it for $200 million (HK$1.55 billion). With the news reaching the market the shares of the Hong Kong-listed biopharmaceutical… Read More ›
pharmaceutical
GlaxoSmithKline sells 100% stake in Unilever’s Indian business for $3.35 billion
On Thursday, in a statement GlaxoSmithKline said, it has agreed to sell 100% of stake in Unilever’s Indian business for nearly $3.35 billion (around 254.8 billion rupees) on the open market. The development marks the British multinational pharmaceutical company cashing… Read More ›
Pfizer Inc to acquire Array Biopharma Inc for $10.64 billion
The deal will not only add to Pfizer’s EPS, but will also provide to stronger traction in the cancer drugs market. U.S. pharmaceutical giant Pfizer Inc stated it would acquire Array Biopharma Inc for $10.64 billion in cash. The potential… Read More ›
Swiss pharmaceutical giant Novartis appoints Susanne Schaffert to lead its oncology business
Susanne Schaffert will be replacing Liz Barrett who will return to the U.S. to head a U.S. biotech firm. Swiss pharmaceutical giant Novartis has stated, it has appointed Susanne Schaffert, a veteran, as the head of its oncology business. She… Read More ›
Cigna Corp overpaying for acquiring Express Scripts Holding Co: Carl Icahn
The deal, as pointed out by Carl Icahn’s letter to Cigna’s shareholders, has at least two significant areas of concern. On Tuesday, billionaire investor Carl Icahn urged Cigna Corp’s shareholders to vote against Cigna’s $52 billion acquisition of Express Scripts… Read More ›
Swiss pharmaceutical giant Novartis to divest its Alcon eye care devices business
The move is aimed at sharpening it focus on its prescription drugs business. On Friday, Novartis disclosed its plans of divesting all of its assets from its Alcon eye care devices business as it sharpens its focus on prescription drugs…. Read More ›